22 May Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review
Posted at 18:39h
in COVID-19
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" css=".vc_custom_1584737067410{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}" z_index=""][vc_column css=".vc_custom_1584737077948{margin-top: 0px !important;}"][vc_column_text css=".vc_custom_1590165411267{margin-top: 0px !important;padding-top: 0px !important;}"]Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C,...